Bengaluru: Indegene, a Bengaluru-headquartered life sciences commercialization and AI-native technology partner, has officially joined the Indo-UK Life Sciences Innovation Corridor as its first industry partner, collaborating alongside the Center for Cellular and Molecular Platforms (C-CAMP) and Imperial College London. The strategic partnership was announced at a joint C-CAMP–Imperial Roundtable on International Partnerships for AI Discovery and Innovation, held under the Government of Karnataka's Global Innovation Alliance initiative as part of the Bengaluru Tech Summit 2026.
Launched earlier in 2026 with support from Imperial Global India, the corridor aims to connect India's deep-science biotech ecosystem with the United Kingdom's premier academic research network to accelerate scalable healthcare and life sciences solutions.
Indo-UK Life Sciences Corridor Partnership: Key Overview
| Particulars | Details |
| Initiative Name | Indo-UK Life Sciences Innovation Corridor |
| Academic & Incubation Leads | Center for Cellular and Molecular Platforms (C-CAMP), Bengaluru & Imperial College London |
| First Industry Partner | Indegene |
| Supporting Framework | Imperial Global India & Govt. of Karnataka's Global Innovation Alliance (Bengaluru Tech Summit 2026) |
| Initial Focus Areas | Antimicrobial Resistance (AMR), Diagnostics, Digital Health, Agritech, Brain Science & Mental Health |
| Core Activities | Co-developing entrepreneurship programs, two-way talent & startup exchanges, ecosystem immersion |
Priority Focus Areas and Scope of Collaboration
Under the newly expanded framework, C-CAMP, Imperial College London, and Indegene will establish structured pathways for two-way sharing of knowledge, research capabilities, and commercial readiness between India and the UK.
Initial priority sectors identified for joint research and startup incubation include:
-
Antimicrobial Resistance (AMR)
-
Diagnostics
-
Digital Health
-
Agritech
-
Brain Science
-
Mental Health
As the first industry anchor, Indegene will bring real-world commercial and regulatory context from working with the world's top biopharma companies, helping define pressing industry problem statements and backing startup exchanges and ecosystem immersion programs.
1. Strengthening Cross-Border Research and Startup Translation
Speaking on the partnership, Dr. Taslimarif Saiyed, CEO of C-CAMP, emphasized that global health challenges cannot be solved in isolation, noting that exposing innovators to both the Imperial College London and C-CAMP ecosystems will generate smarter, more scalable, and accessible solutions for populations in both countries.
Amanda Wolthuizen, Vice-President (Strategy) at Imperial College London, welcomed Indegene as an ideal initial industry collaborator to unite academic research, scientific talent, and enterprise expertise in accelerating emerging technologies.
Dr. Saurabh Jain, Vice-President (Global Delivery Centers, CSR, and Advocacy) at Indegene, stated that the next decade of life sciences innovation depends on connecting science, talent, and industry across borders, giving promising laboratory discoveries a clearer pathway to real-world impact.
2. Institutional Impact on Researchers and Deep-Science Startups
Backed by the Department of Biotechnology (DBT), Government of India, C-CAMP has enabled over 6,000 research projects, trained more than 2,200 scientific personnel, and supported startups that have filed over 1,000 patents and brought more than 420 life sciences products to market.
Combined with Imperial Global India—established by Imperial College London to foster two-way Science, Technology, Engineering, Mathematics, and Business (STEMB) talent flows—the corridor creates valuable mentorship, immersion, and commercialization opportunities for Indian researchers, life sciences students, and early-stage biotech founders.
Important Dates & Milestones
| Event | Timeline |
| Indo-UK Life Sciences Corridor Launch | Earlier in 2026 |
| Indegene Partnership Announcement | November 19, 2026 (Bengaluru Tech Summit 2026) |
Important Links
-
C-CAMP Official Website:
[https://www.ccamp.res.in](https://www.ccamp.res.in) -
Imperial College London (Imperial Global India):
[https://www.imperial.ac.uk](https://www.imperial.ac.uk) -
Indegene Official Newsroom:
[https://www.indegene.com/news](https://www.indegene.com/news)
Frequently Asked Questions (FAQs)
1. Which organizations are part of the Indo-UK Life Sciences Corridor announcement? The Center for Cellular and Molecular Platforms (C-CAMP) and Imperial College London have partnered with Bengaluru-based life sciences company Indegene as the first industry partner of the Indo-UK Life Sciences Innovation Corridor.
2. Where was Indegene's induction into the corridor announced? It was announced on November 19, 2026, at a joint C-CAMP–Imperial roundtable on International Partnerships for AI Discovery and Innovation during the Bengaluru Tech Summit 2026.
3. What role will Indegene play in the Indo-UK Life Sciences Corridor? Indegene will bring industry perspective, help define real-world biopharma and healthcare challenges, co-develop entrepreneurship programmes, and support cross-border startup exchanges and ecosystem immersion initiatives.
4. What are the initial focus areas of the collaboration? The initial priority areas include antimicrobial resistance (AMR), diagnostics, digital health, agritech, brain science, and mental health.
5. How does this partnership benefit Indian students, researchers, and startups? The corridor facilitates two-way STEMB talent exchange, joint entrepreneurship training, ecosystem immersion between India and the UK, and commercial mentorship to help deep-science startups scale their innovations globally.
Click Here for More Latest News